Interestingly, in patients undergoing an allogeneic transplantation, antibody responses to NY-ESO-1 were detected after transplantation, suggesting that this may represent a target for the graft-versus-myeloma effect. This evidence concerns the gene CTAG1B and plasma cell myeloma.